Domov › Rak (vse vrste) › Minnesota › Minneapolis

Klinične študije za Rak (vse vrste) v Minneapolis, MN

22 študij za Rak (vse vrste) išče udeležence na lokacijah v Minneapolis in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

Vključevanje udeležencevFaza 2

University Of Minnesota /ID# 277850, Minneapolis

Starost 18 in več · Ženske · Posodobljeno 1. okt. 2026 · NCT07024784

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Vključevanje udeležencevFaza 2/3

HealthPartners Cancer Research Center /ID# 277339, Saint Louis Park · 5 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07155187

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

Vključevanje udeležencevFaza 3

Metro Minnesota Community Oncology Research Consortium (MMCORC), Saint Louis Park · 5 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06901531

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Vključevanje udeležencevFaza 2/3

M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis

Vse starosti · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT03435796

Connect for Cancer Prevention Study (Connect)

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

HealthPartners, Minneapolis

Starost 30–70 · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT04609072

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Vključevanje udeležencevFaza 3

Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis

Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06119581

Project: Every Child for Younger Patients With Cancer

Vključevanje udeležencevOpazovalna študija

Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
University of Minnesota/Masonic Cancer Center, Minneapolis

Do 25 let · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT02402244

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Vključevanje udeležencevFaza 1/2

M Health Fairview University of Minnesota Medical Center, Minneapolis

Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT05919264

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

Vključevanje udeležencevFaza 2

University of Minnesota Hospital, Minneapolis

Starost 1–39 · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT05999994

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Vključevanje udeležencevFaza 3

Abbott-Northwestern Hospital, Minneapolis
Hennepin County Medical Center, Minneapolis
Health Partners Inc, Minneapolis
in še 2

Starost 18 in več · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT06580314

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Vključevanje udeležencevFaza 2

518, Minneapolis

Starost 18 in več · Ženske · Posodobljeno 16. jul. 2026 · NCT06906341

Capturing Food Intake in Patients Undergoing Radiation Therapy for Cancer

Vključevanje udeležencev

University Of Minnesota, Minneapolis

Starost 18 in več · Vsi spoli · Posodobljeno 14. jul. 2026 · NCT07682714

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

Vključevanje udeležencevFaza 2

Scri Minnesota Oncology Hematology, P.A. /ID# 275149, Minneapolis

Starost 18 in več · Vsi spoli · Posodobljeno 10. jul. 2026 · NCT07023289

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Vključevanje udeležencevOpazovalna študija

VPCI Oncology Research, Minneapolis

Starost 18 in več · Vsi spoli · Posodobljeno 10. jul. 2026 · NCT05181826

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

Vključevanje udeležencevFaza 1

GSK Investigational Site, Minneapolis

Starost 18 in več · Vsi spoli · Posodobljeno 25. jun. 2026 · NCT06431594

Childhood Cancer Survivor Study

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Children's Hospitals & Clinics of Minnesota, Minneapolis

Vse starosti · Vsi spoli · Posodobljeno 17. jun. 2026 · NCT01120353

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Vključevanje udeležencevFaza 1/2

Children's Hospital and Clinics of Minn, Minneapolis

12 Months – 30 Years · Vsi spoli · Posodobljeno 19. maj 2026 · NCT04901702

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Vključevanje udeležencevFaza 2

University of Minnesota, Minneapolis
Metro Minnesota Community Oncology Research Consortium, Hennepin County Medical Center, Saint Louis Park · 5 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 6. maj 2026 · NCT01042379